REPORT/RECOMMENDATION TO THE BOARD OF SUPERVISORS
OF SAN BERNARDINO COUNTY
AND RECORD OF ACTION
July 23, 2024
FROM
ANDREW GOLDFRACH, ARMC Chief Executive Officer, Arrowhead Regional Medical Center
SUBJECT
Title
Agreement with Jubilant DraxImage, Inc. dba Jubilant Radiopharma for Radioactive Pharmaceutical Agents
End
RECOMMENDATION(S)
Recommendation
Approve agreement, including non-standard terms, with Jubilant DraxImage, Inc. dba Jubilant Radiopharma for the preparation and delivery of radioactive pharmaceutical agents, in the not-to-exceed amount of $1,212,000, for the contract period of July 23, 2024 through July 22, 2029.
(Presenter: Andrew Goldfrach, ARMC Chief Executive Officer, 580-6150)
Body
COUNTY AND CHIEF EXECUTIVE OFFICER GOALS & OBJECTIVES
Provide for the Safety, Health and Social Service Needs of County Residents.
FINANCIAL IMPACT
Approval of this item will not result in the use of Discretionary General Funding (Net County Cost). The cost of $1,212,000 is funded by State Medi-Cal, Federal Medicare, private insurances, and other departmental revenue. Funding sources may change in the future pending any legislative activity related to the repeal and/or replacement of the Affordable Care Act. Adequate appropriation and revenue have been included in the Arrowhead Regional Medical Center (ARMC) 2024-25 budget and will be included in future recommended budgets.
BACKGROUND INFORMATION
The agreement with Jubilant DraxImage, Inc. dba Jubilant Radiopharma (Jubilant) will allow the ARMC Medical Imaging Department to receive radioactive pharmaceutical agents, such as isotopes, which are used to perform diagnostic and therapeutic imaging procedures. Jubilant is a licensed nuclear pharmacy provider that prepares and delivers radioactive pharmaceutical agents to medical imaging centers. The agreement also provides access to Jubilant's clinical education professionals for training and educational programs, and use of the company's Nucle...
Click here for full text